Guangzhou Yuexiu Industrial Investment Fund logo

Guangzhou Yuexiu Industrial Investment Fund

Asia, Guangdong, China, Guangzhou

Description

Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.

Investor Profile

Guangzhou Yuexiu Industrial Investment Fund has backed more than 10 startups, with 2 new investments in the last 12 months alone. The firm has led 5 rounds, about 50% of its total and boasts 9 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Angel rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Manufacturing, Medical Device.
  • Led 1 rounds in the past year.

Stage Focus

  • Series C (50%)
  • Series B (30%)
  • Angel (10%)
  • Series A (10%)

Country Focus

  • China (90%)
  • United States (10%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Medical Device
  • Pharmaceutical
  • Health Care
  • Aerospace
  • Artificial Intelligence (Ai)
  • Information Technology
  • Internet
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Guangzhou Yuexiu Industrial Investment Fund frequently co-invest with?

HE
Asia, Beijing, China, Beijing
Co-Investments: 1
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Chongqing Liangjiang Service Industry Fund
Asia, Chongqing, China, Jiangbei
Co-Investments: 1
Co-Investments: 1
BC
North America, California, United States, Palo Alto
Co-Investments: 1
Granary Capital
Asia, Liaoning, China, Chaoyang
Co-Investments: 1
Hony Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
QS
North America, Colorado, United States, Denver
Co-Investments: 1
Sangel Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 3

What are some of recent deals done by Guangzhou Yuexiu Industrial Investment Fund?

Jiangsu Jland Biotech

Nanjing, Jiangsu, China

Jiangsu Jland Biotech develops and produces Biollagen, a non-animal sourced collagen.

BiotechnologyLife Science
Series CMay 26, 2025
Amount Raised: $13,914,205
HongQing Technology

Daxing, Beijing, China

HongQing Technology is a satellite networking solution provider.

AerospaceManufacturingSatellite Communication
Series AJan 23, 2025
Amount Raised: $41,167,511
EurekaBio

Shenzhen, Guangdong, China

EurekaBio is a biotechnology company that offers solutions for cancer immunotherapy.

BiotechnologyHealth CareMedical
Series BFeb 21, 2024
Amount Raised: $41,731,002
Sonosemi Medical

Shenzhen, Guangdong, China

Sonosemi Medical is a provider of medical devices that specializes in pan-vascular active interventional diagnosis and treatment solutions.

Health DiagnosticsManufacturingMedical Device
Series BOct 26, 2023
Amount Raised: $27,337,716
Guangyu Mingdao

Yubei, Chongqing, China

Guangyu Mingdao is an industrial internet platform.

Artificial Intelligence (AI)Information TechnologyInternet
AngelSep 26, 2023
Astronergy

Hangzhou, Zhejiang, China

Astronergy specializes in the research, development, and production of solar modules.

EnergyIndustrialManufacturingSolar
Series CJul 25, 2023
Amount Raised: $280,257,276
REDPINE

Guangdong, Jilin, China

REDPINE is a medical healthcare instrument providing industry.

Health Care
Series CDec 9, 2022
XAG

Guangzhou, Guangdong, China

XAG is a drone service provider company for agricultural industry.

AerospaceAgricultureDronesFarmingInnovation ManagementManufacturing
Series CNov 16, 2020
Amount Raised: $182,237,881
Sirnaomics

Gaithersburg, Maryland, United States

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

BiopharmaBiotechnologyMedical DevicePharmaceutical
Series CJun 6, 2018
Amount Raised: $25,000,000
IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series BFeb 22, 2016
Amount Raised: $10,000,000